How has Emergent Biosolutions's allowance for doubtful accounts changed year-over-year?

Emergent Biosolutions's allowance for doubtful accounts decreased by 33.3% year-over-year, from $1.2M to $800K.

What is the long-term trend for Emergent Biosolutions's allowance for doubtful accounts?

Over 5 years (2020 to 2025), Emergent Biosolutions's allowance for doubtful accounts has grown at a -23.7% compound annual growth rate (CAGR), from $3.1M to $800K.

Emergent Biosolutions EBS Allowance for Doubtful Accounts

Allowance for Doubtful Accounts at other companies

Thermo Fisher ScientificTMO

——

Medline, Inc. MDLN

——

Indivior Pharmaceuticals, Inc. INDV

——

Charles River LaboratoriesCRL

——

Rapid7RPD

——

Baxter InternationalBAX

——

Other financials

Income statement

See full

Revenue$156.1M-29.7%

Gross profit$84.1M-37.1%

Operating income$10.5M-79.0%

Net income$6.8M-90.0%

EPS (diluted)$0.07-94.1%

Balance sheet

See full

Cash & equivalents$161.5M+5.7%

Total debt$584.6M-13.1%

Total equity$523.1M-5.4%

Total assets$1.3B-7.4%

Cash flow

See full

Operating cash flow-$33.8M-202%

CapEx$2.4M-33.3%

Free cash flow-$36.2M-145%

Valuation

See full

Market cap$411.74M+22.0%

Enterprise value$834.84M-2.6%

P/E3.6×—

P/S0.6×+0.3×

Profitability

See full

Gross margin54.2%+19.0pp

Operating margin15%+10.3pp

Net margin9.6%+5.8pp

FCF margin20.8%—

Returns & leverage

See full

Return on equity13.9%+8.1pp

Debt / equity1.1×-0.1×

Current ratio4.3×-2.0×

Where this comes from

Reported directly by Emergent Biosolutions in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivable.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's allowance for doubtful accounts.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Emergent Biosolutions's allowance for doubtful accounts?: Emergent Biosolutions (EBS) reported allowance for doubtful accounts of $800K in Q1 2026.
How has Emergent Biosolutions's allowance for doubtful accounts changed year-over-year?: Emergent Biosolutions's allowance for doubtful accounts decreased by 33.3% year-over-year, from $1.2M to $800K.
What is the long-term trend for Emergent Biosolutions's allowance for doubtful accounts?: Over 5 years (2020 to 2025), Emergent Biosolutions's allowance for doubtful accounts has grown at a -23.7% compound annual growth rate (CAGR), from $3.1M to $800K.